Skip to main content
OpenTrials
Completed

NCT Number: NCT07305376

Older Adults' Attitudes Towards Stopping Aspirin

This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medication Overuse Chemically-Induced Disorders Drug Misuse Mental Disorders Prescription Drug Misuse Prescription Drug Overuse Substance-Related Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Reside in Australia or the United States
  • 65 years and older

Exclusion criteria

  • Unable to read survey written in English

Treatment and study plan

Additional harm information

Other

Participants received additional information about the harm of continuing aspirin.

Less information

Other

Participants will receive less information about the risk of harms of continuing aspirin.

Primary outcomes

  1. "How safe do you think it would be to continue taking aspirin?" measured on a 6-point Likert scale

    Time frame: Day 1

  2. "How helpful do you think it would be to continue taking aspirin?" measured on a 6-point Likert scale

    Time frame: Day 1

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • University of Sydney

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 26, 2025
Registry last updated
Apr 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.